MK
Mittal Ketan Shah
About Mittal Ketan Shah
Data last updated:
Mittal Ketan Shah is a Director at Smick Laboratories Private Limited (since 2014) and Director at Ketan Pharma Chem Private Limited (since 2022). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹21.04 Cr; the largest is Smick Laboratories Private Limited at ₹18.46 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Smick Laboratories Private Limited U74120MH2014PTC256879 | Director | 05 Aug 2014 | 2014 | ₹18.46 Cr (FY 2024) | Active |
 Ketan Pharma Chem Private Limited U51909MH2022PTC391694 | Director | 07 Oct 2022 | 2022 | ₹2.58 Cr (FY 2024) | Active |
Board colleagues of Mittal Ketan Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashish Kumar Jajodia | 00299794 | Smick Laboratories Private Limited | Director |
| Ketan Dinesh Shah | 06619636 | Smick Laboratories Private Limited , Ketan Pharma Chem Private Limited | Director |
| Manish Kumar Jajodia | 00299619 | Smick Laboratories Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mittal Ketan Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mittal Ketan Shah
Mittal Ketan Shah currently holds 2 directorships: Smick Laboratories Private Limited (Director, since 05 Aug 2014, revenue ₹18.46 Cr (FY 2024)); Ketan Pharma Chem Private Limited (Director, since 07 Oct 2022, revenue ₹2.58 Cr (FY 2024)).
Mittal Ketan Shah was first appointed on 05 Aug 2014 as Director at Smick Laboratories Private Limited. The most recent appointment on record is 07 Oct 2022 at Ketan Pharma Chem Private Limited.
The 2 current companies of Mittal Ketan Shah that report revenue have a combined latest revenue of ₹21.04 Cr: Smick Laboratories Private Limited ₹18.46 Cr (FY 2024); Ketan Pharma Chem Private Limited ₹2.58 Cr (FY 2024).
The current boards of Mittal Ketan Shah's companies include Ashish Kumar Jajodia (Smick Laboratories Private Limited), Ketan Dinesh Shah (Smick Laboratories Private Limited), Manish Kumar Jajodia (Smick Laboratories Private Limited).